Skip to main content

Table 2 Characteristics of patients of GCTBa treated with curettage from 2008 to 2010

From: Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

Characteristics No. of patients (%)
Primary tumor site
 Extremity 151 (96%)
 Trunk 7 (4%)
Campanacci grade
 Grade I 16 (10%)
 Grade II 97 (61%)
 Grade III 45 (29%)
Pathological fracture at presentation
 Yes 26 (16%)
 No 132 (84%)
Do you use denosumab for this case now?
 Yes 83 (52%)
 No 75 (48%)
Embolization before surgery
 Yes 8 (5%)
 No 150 (95%)
  1. aGCTB, giant cell tumor of bone